Covington Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.1M | Sell |
28,728
-1,532
| -5% | -$831K | 2.08% | 14 |
|
|
2025
Q4 | $17.5M | Sell |
30,260
-3,830
| -11% | -$2.17M | 2.4% | 12 |
|
|
2025
Q3 | $16.5M | Buy |
34,090
+63
| +0.2% | +$29.3K | 2.16% | 14 |
|
|
2025
Q2 | $13.8M | Buy |
34,027
+1,810
| +6% | +$757K | 1.97% | 18 |
|
|
2025
Q1 | $16M | Buy |
32,217
+847
| +3% | +$459K | 2.49% | 13 |
|
|
2024
Q4 | $16.3M | Sell |
31,370
-285
| -0.9% | -$157K | 2.45% | 11 |
|
|
2024
Q3 | $19.6M | Buy |
31,655
+123
| +0.4% | +$72.8K | 2.94% | 6 |
|
|
2024
Q2 | $17.4M | Sell |
31,532
-1,454
| -4% | -$833K | 2.8% | 8 |
|
|
2024
Q1 | $19.2M | Buy |
32,986
+808
| +3% | +$453K | 3.13% | 5 |
|
|
2023
Q4 | $17.1M | Buy |
32,178
+1,545
| +5% | +$748K | 3.1% | 4 |
|
|
2023
Q3 | $15.5M | Buy |
30,633
+1,092
| +4% | +$582K | 3.18% | 4 |
|
|
2023
Q2 | $15.4M | Buy |
29,541
+1,898
| +7% | +$1.02M | 3.08% | 4 |
|
|
2023
Q1 | $15.9M | Buy |
27,643
+50
| +0.2% | +$28.2K | 3.5% | 4 |
|
|
2022
Q4 | $15.2M | Buy |
27,593
+485
| +2% | +$257K | 3.63% | 4 |
|
|
2022
Q3 | $13.7M | Buy |
27,108
+338
| +1% | +$189K | 3.56% | 4 |
|
|
2022
Q2 | $14.5M | Sell |
26,770
-18
| -0.1% | -$9.91K | 3.68% | 4 |
|
|
2022
Q1 | $15.8M | Buy |
26,788
+1,740
| +7% | +$1,000K | 3.31% | 5 |
|
|
2021
Q4 | $16.7M | Buy |
25,048
+23
| +0.1% | +$14.4K | 3.4% | 5 |
|
|
2021
Q3 | $14.3M | Buy |
25,025
+400
| +2% | +$220K | 3.08% | 6 |
|
|
2021
Q2 | $12.4M | Buy |
24,625
+1,739
| +8% | +$821K | 2.73% | 8 |
|
|
2021
Q1 | $10.4M | Buy |
22,886
+862
| +4% | +$411K | 2.52% | 10 |
|
|
2020
Q4 | $10.3M | Buy |
22,024
+488
| +2% | +$229K | 2.65% | 12 |
|
|
2020
Q3 | $9.51M | Buy |
21,536
+1,970
| +10% | +$814K | 2.73% | 11 |
|
|
2020
Q2 | $7.09M | Buy |
19,566
+260
| +1% | +$87.1K | 2.18% | 14 |
|
|
2020
Q1 | $5.47M | Buy |
19,306
+735
| +4% | +$232K | 2.08% | 12 |
|
|
2019
Q4 | $6.03M | Buy |
18,571
+3,620
| +24% | +$1.1M | 1.86% | 15 |
|
|
2019
Q3 | $4.36M | Hold |
14,951
| – | – | 1.48% | 24 |
|
|
2019
Q2 | $4.39M | Buy |
14,951
+110
| +0.7% | +$30.3K | 1.43% | 24 |
|
|
2019
Q1 | $4.06M | Buy |
14,841
+345
| +2% | +$85.9K | 1.37% | 29 |
|
|
2018
Q4 | $3.24M | Sell |
14,496
-157
| -1% | -$36.8K | 1.23% | 37 |
|
|
2018
Q3 | $3.58M | Sell |
14,653
-130
| -0.9% | -$29.9K | 1.16% | 38 |
|
|
2018
Q2 | $3.06M | Hold |
14,783
| – | – | 1.05% | 44 |
|
|
2018
Q1 | $3.05K | Buy |
14,783
+625
| +4% | +$131K | 0.98% | 42 |
|
|
2017
Q4 | $2.69M | Buy |
14,158
+395
| +3% | +$75.7K | 0.92% | 50 |
|
|
2017
Q3 | $2.6M | Sell |
13,763
-395
| -3% | -$71.5K | 0.98% | 47 |
|
|
2017
Q2 | $2.47M | Hold |
14,158
| – | – | 0.94% | 50 |
|
|
2017
Q1 | $2.17M | Buy |
14,158
+460
| +3% | +$70.3K | 0.87% | 54 |
|
|
2016
Q4 | $1.93M | Buy |
+13,698
| New | +$2.02M | 0.82% | 58 |
|
Other funds holding TMO
VCM
Covington Investment Advisors's TMO Position: Q1 2026 in Review
Covington Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 5.1% in Q1 2026, selling an estimated $831K and leaving 28,728 shares worth $14.1M. The position accounts for 2.08% of the portfolio, ranked #14.
Covington Investment Advisors first reported a position in TMO in Q4 2016 and has held it in 38 quarters since. The position peaked at $19.6M in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Covington Investment Advisors held 28,728 shares of Thermo Fisher Scientific worth $14.1M as of Q1 2026.
- Covington Investment Advisors sold 1,532 Thermo Fisher Scientific shares in Q1 2026, an estimated $831K.
- Thermo Fisher Scientific made up 2.08% of Covington Investment Advisors's portfolio in Q1 2026, its #14 holding.
- Covington Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 38 quarters since.
- Covington Investment Advisors's Thermo Fisher Scientific position peaked at $19.6M in Q3 2024.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Covington Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.